Back
Actinium Pharmaceuticals Vs. Perspective Therapeutics Industry Stock Comparison
Buy
56
ATNM
Actinium Pharmaceuticals
Last Price:
9.75
Seasonality Move:
-2.01%
Buy
61
CATX
Perspective Therapeutics
Last Price:
1.54
Seasonality Move:
2.36%
Buy
56
Actinium Pharmaceuticals (ATNM)
is a Buy
Is Actinium Pharmaceuticals a Buy, Sell or Hold?
- The current Actinium Pharmaceuticals [ATNM] share price is $9.85. The Score for ATNM is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- ATNM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.53. The Score for CATX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ATNM Stock Price Chart
What is Actinium Pharmaceuticals's stock price today?
-
The Actinium Pharmaceuticals share price today is $9.85
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATNM is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.53
The current trend is moderately bearish and CATX is experiencing slight buying pressure.
ATNM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.47 | Buy |
| Relative Strength Index (14 RSI): | 67.06 | Buy |
| Chaikin Money Flow: | 86667 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.11 - 9.17) | Buy |
| Bollinger Bands (100): | (5.5 - 8.56) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 44.05 | Sell |
| Chaikin Money Flow: | 1336950 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.51 - 1.77) | Sell |
| Bollinger Bands (100): | (0.65 - 1.51) | Buy |
ATNM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.19 | Buy |
| 20-day SMA: | 8.22 | Buy |
| 50-day SMA: | 8.14 | Buy |
| 200-day SMA: | 6.35 | Buy |
| 8-day EMA: | 9.26 | Buy |
| 20-day EMA: | 8.68 | Buy |
| 50-day EMA: | 8.07 | Buy |
| 200-day EMA: | 7.09 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.72 | Sell |
| 20-day SMA: | 1.69 | Sell |
| 50-day SMA: | 1.45 | Buy |
| 200-day SMA: | 0.7 | Buy |
| 8-day EMA: | 1.67 | Sell |
| 20-day EMA: | 1.65 | Sell |
| 50-day EMA: | 1.46 | Buy |
| 200-day EMA: | 0.9 | Buy |
Actinium Pharmaceuticals Earnings Growth & ATNM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.46 per share, an increase this year of $0.45 per share, and an increase next year of $1.05 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Actinium Pharmaceuticals Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||